Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders

NCT01337687 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorders

Interventions

DRUG: Intranasal Oxytocin
DRUG: Placebo

Sponsor

Montefiore Medical Center

Collaborators

[object Object]